Pacira BioSciences
PCRX
PCRX
272 hedge funds and large institutions have $2.67B invested in Pacira BioSciences in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 116 increasing their positions, 83 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $2.82B → $2.67B (-$150M)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
43% less call options, than puts
Call options by funds: $3.31M | Put options by funds: $5.79M
Holders
272
Holding in Top 10
5
Calls
$3.31M
Puts
$5.79M
Top Buyers
| 1 | +$53.2M | |
| 2 | +$23.2M | |
| 3 | +$20.4M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$12.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.4M |
Top Sellers
| 1 | -$33.5M | |
| 2 | -$20.4M | |
| 3 | -$11.3M | |
| 4 |
SCM
Spyglass Capital Management
San Francisco,
California
|
-$11.1M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$8.93M |